Skip to main content
FinSpry Logo
FinSpry
PRQR logo
PRQR
(NASDAQ)
ProQR Therapeutics N.V.
$1.50-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

ProQR Therapeutics (PRQR) Stock Price & Financial Analysis

ProQR Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$1.48 - $1.55
52-Week High$3.10
52-Week Low$1.33
Open$1.53
Volume449.72K
Average Volume (3M)658.04K
Market Cap161.16M
Shares Outstanding105.33M
Price to Sales (P/S)8.79
Price to Book (P/B)2.83
EV/EBITDA-1.59
Revenue (TTM)18.33M
Net Income (TTM)-48.60M
Free Cash Flow (TTM)-62.00M
EPS (TTM)$-0.46
Profit Margin-265.21%
Operating Margin-273.14%
Return on Equity (ROE)-85.44%
Debt to Equity0.28
50-Day MA$1.64
200-Day MA$1.95
52-Week Change-16.20%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About ProQR Therapeutics

What is the current stock price for PRQR?

As of the latest trading session, PRQR stock trades at $1.50. The 52-week range is $1.33–$3.10, with a day range of $1.48–$1.55.

What is the P/E ratio for PRQR?

The P/E ratio (Price-to-Earnings) for PRQR is shown in the Key Statistics section. This valuation metric helps compare ProQR Therapeutics N.V. to industry peers.

Does PRQR pay dividends?

ProQR Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for PRQR?

Based on 1 analyst, the consensus for PRQR is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of PRQR?

ProQR Therapeutics's market capitalization is $158.0M, classifying it as a micro-cap company..